台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.35
  • 漲跌
    ▲0.30
  • 漲幅
    +1.25%
  • 成交量
    241
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/15     後一日»

券商獲利排行 - 2024/04/15

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.09%18.20.118.1-6626824.624.624.624.4
  1.02%11.6-0.311.9-4424624.624.824.624.4
  1.43%7.40.17.3-2012124.724.624.724.4
  1.42%6.606.6-1901924.7024.724.4
  0.74%3.4-0.13.6-1811924.624.724.624.4
  1.22%303-1001024.7024.724.4
  1.62%2.802.8-70724.8024.824.4
  0.81%2.202.2-1101124.6024.624.4
  0.81%202-1001024.6024.624.4
  0.59%1.7-0.42.1-751224.724.724.724.4
  0.61%1.501.5-1001024.5024.524.4
  1.06%1.301.3-50524.6024.624.4
  1.02%1.201.2-50524.6024.624.4
  1.22%0.900.9-30324.7024.724.4
  0.81%0.800.8-40424.6024.624.4
  1.42%0.700.7-20224.7024.724.4
  1.42%0.700.7-20224.7024.724.4
  0.81%0.600.6-30324.6024.624.4
  0.81%0.600.6-30324.6024.624.4
  1.81%0.400.4-10124.8024.824.4
  0.61%0.300.3-20224.5024.524.4
  0.61%0.300.3-20224.5024.524.4
  0.81%0.20.2001124.724.624.824.4
  0.41%0.200.2-11224.624.624.624.4
  0.61%0.10.1001124.624.624.724.4
  0.61%0.100.1-10124.5024.524.4
  0.61%0.100.1-10124.5024.524.4
  0.20%0.10.1002224.724.724.724.4
  0.20%0.10.1001124.524.524.624.4
   00000024.824.8024.4
   00000024.524.5024.4
   00000024.5024.524.4
   00000024.724.7024.4
   00000024.824.8024.4
  0.00%00001124.824.824.824.4
   00000024.9024.924.4
   00000024.9024.924.4
   00000024.9024.924.4
   00000024.724.7024.4
   00000024.824.8024.4
   00000024.724.7024.4
   00000024.924.9024.4
   00000024.824.8024.4
   00000024.6024.624.4
   00000024.8024.824.4
   00000024.824.8024.4
   00000024.7024.724.4
   00000024.824.8024.4
   00000024.7024.724.4
   00000024.824.8024.4

券商虧損排行 - 2024/04/15

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.02%-9.50-9.53838024.624.6024.4
  -1.04%-5.90-5.92323024.624.6024.4
  -1.36%-50-51515024.724.7024.4
  -1.10%-40-41515024.624.6024.4
  -1.14%-2.80-2.81010024.624.6024.4
  -1.02%-2.50-2.51010024.624.6024.4
  -1.81%-2.20-2.255024.824.8024.4
  -1.25%-2.10-2.177024.724.7024.4
  -1.42%-2.10-2.166024.724.7024.4
  -1.72%-1.70-1.744024.824.8024.4
  -1.15%-1.70-1.766024.624.6024.4
  -0.81%-1.60-1.688024.624.6024.4
  -1.32%-1.30-1.344024.724.7024.4
  -1.12%-1.10-1.144024.624.6024.4
  -1.42%-10-133024.724.7024.4
  -2.01%-10-122024.924.9024.4
  -0.81%-10-155024.624.6024.4
  -0.92%-0.90-0.944024.624.6024.4
  -0.83%-0.8-0.4-0.404324.724.724.624.4
  -1.02%-0.70-0.733024.624.6024.4
  -1.02%-0.70-0.733024.624.6024.4
  -1.02%-0.70-0.733024.624.6024.4
  -0.61%-0.70-0.755024.524.5024.4
  -0.61%-0.70-0.755024.524.5024.4
  -1.42%-0.70-0.722024.724.7024.4
  -1.32%-0.60-0.622024.724.7024.4
  -1.32%-0.60-0.622024.724.7024.4
  -1.32%-0.60-0.622024.724.7024.4
  -1.22%-0.60-0.622024.724.7024.4
  -1.22%-0.60-0.622024.724.7024.4
  -0.81%-0.60-0.633024.624.6024.4
  -1.12%-0.50-0.522024.624.6024.4
  -1.12%-0.50-0.522024.624.6024.4
  -1.02%-0.50-0.522024.624.6024.4
  -1.02%-0.50-0.522024.624.6024.4
  -0.92%-0.40-0.422024.624.6024.4
  -1.62%-0.40-0.411024.824.8024.4
  -1.62%-0.40-0.411024.824.8024.4
  -0.81%-0.40-0.422024.624.6024.4
  -0.81%-0.40-0.422024.624.6024.4
  -0.81%-0.40-0.422024.624.6024.4
  -1.59%-0.40-0.411024.724.724.624.4
  -1.42%-0.30-0.311024.724.7024.4
  -0.71%-0.30-0.312124.724.724.724.4
  -0.61%-0.3-0.3002224.624.724.624.4
  -1.22%-0.30-0.311024.724.7024.4
  -1.22%-0.30-0.311024.724.7024.4
  -1.22%-0.30-0.311024.724.7024.4
  -1.22%-0.30-0.311024.724.7024.4
  -1.22%-0.30-0.311024.724.7024.4
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章